Volpara Health Technologies Ltd, a global leader in software for the early detection of cancer, is attending this year's National Consortium of Breast Centers...
Incyte announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor,...
Cover Whale Insurance Solutions, Inc., a leading commercial trucking insurance provider and fast-growing insurtech, announces its partnership with TrustedChoice.com, the nation's largest digital marketing...
Lattice Semiconductor, the low power programmable leader, announced that it won two Artificial Intelligence Excellence Awards from The Business Intelligence Group. The Lattice Avant™...
AbbVie announced topline results from a Phase 2 study of upadacitinib given alone or as combination therapy (ABBV-599) with a Bruton's Tyrosine Kinase inhibitor (elsubrutinib,...
